Description

Febumin is a pharmaceutical medication manufactured by MEDPHARM Research Ltd, designed primarily for the management and treatment of gout. Each box contains 20 tablets, with each tablet delivering a strong 80mg dose of the active ingredient, Febuxostat. Febuxostat works by inhibiting xanthine oxidase, an enzyme responsible for the production of uric acid in the body. By effectively lowering high uric acid levels in the bloodstream, Febumin prevents the formation and buildup of painful uric acid crystals around the joints. This long-term maintenance treatment helps significantly reduce and prevent future gout attacks, allowing patients to manage the chronic condition more comfortably.